// App-Quantinova.ai

1357 ⋆ : Circulating Tumour Cell (CTC) biomarkers and the stratification of therapy for patients with hepatocellular carcinoma

Researchers

Presenter

  • Misti V. McCain

Principal Investigators

  • Laura Ogle

  • Jane Margetts

  • Stuart McPherson

  • Steven Masson

  • Mark Hudson

  • Ruchi Shukla

  • David Jamieson

  • Helen Reeves

Medical Centers

  • Northern Institute For Cancer Research, Newcastle upon Tyne, United Kingdom.

  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Liver cancer

  • Solid malignancies

  • Acquired immunodeficiency syndrome

Biomarkers

  • Breakpoint Cluster Region

  • Nucleoside diphosphate kinase A

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Extracellular signal-regulated kinase

  • Fibroblast growth factor receptor 4

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved